| 1 |
35222033 | Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression. | 2022 |
1 |
| 2 |
34051224 | Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells. | 2021 Jul |
1 |
| 3 |
30504232 | Hepatic transcriptome analysis from HFD-fed mice defines a long noncoding RNA regulating cellular cholesterol levels. | 2019 Feb |
1 |
| 4 |
30129056 | Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway. | 2018 Nov |
1 |
| 5 |
25736301 | Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. | 2015 Jul |
1 |
| 6 |
21205704 | DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle. | 2011 Apr |
1 |
| 7 |
19285478 | Liver type fatty acid binding protein (L-FABP) gene ablation reduces nuclear ligand distribution and peroxisome proliferator-activated receptor-alpha activity in cultured primary hepatocytes. | 2009 May 15 |
1 |
| 8 |
11246888 | Direct regulatory effect of fatty acids on macrophage lipoprotein lipase: potential role of PPARs. | 2001 Mar |
1 |
| 9 |
10801788 | Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. | 2000 Jul 21 |
1 |
| 10 |
9488698 | Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). | 1998 Mar 6 |
1 |